Page last updated: 2024-08-21

c.i. 42510 and Brain Edema

c.i. 42510 has been researched along with Brain Edema in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Beker, M; Beker, MC; Caglayan, AB; Caglayan, B; Kelestemur, T; Kilic, E; Kilic, U; Ozturk, G; Sahin, F; Sertel, E; Yalcin, E	1
Chen, S; Hu, Q; Krafft, PR; Ma, Q; Rolland, W; Sherchan, P; Tang, J; Zhang, J; Zhang, JH	1
Cui, CM; Cui, JZ; Cui, Y; Gao, JL; Li, R; Sun, LQ; Tian, YX; Wang, YC; Zhang, HA; Zhu, HX	1

Trials

1 trial(s) available for c.i. 42510 and Brain Edema

Article	Year
P2X7R/cryopyrin inflammasome axis inhibition reduces neuroinflammation after SAH. Neurobiology of disease, 2013, Volume: 58 Topics: Adenosine Triphosphate; Animals; Brain Edema; Carrier Proteins; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Encephalitis; Injections, Intraventricular; Lipopolysaccharides; Male; NLR Family, Pyrin Domain-Containing 3 Protein; Platelet Aggregation Inhibitors; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; Receptors, Purinergic P2X7; RNA, Small Interfering; Rosaniline Dyes; Signal Transduction; Subarachnoid Hemorrhage	2013

Article

Year

P2X7R/cryopyrin inflammasome axis inhibition reduces neuroinflammation after SAH.

Neurobiology of disease, 2013, Volume: 58

Topics: Adenosine Triphosphate; Animals; Brain Edema; Carrier Proteins; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Encephalitis; Injections, Intraventricular; Lipopolysaccharides; Male; NLR Family, Pyrin Domain-Containing 3 Protein; Platelet Aggregation Inhibitors; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; Receptors, Purinergic P2X7; RNA, Small Interfering; Rosaniline Dyes; Signal Transduction; Subarachnoid Hemorrhage

2013

Other Studies

2 other study(ies) available for c.i. 42510 and Brain Edema

Article	Year
Evidence that activation of P2X7R does not exacerbate neuronal death after optic nerve transection and focal cerebral ischemia in mice. Experimental neurology, 2017, Volume: 296 Topics: Adenosine Triphosphate; Animals; Animals, Newborn; Brain; Brain Edema; Brain Ischemia; Calcium-Binding Proteins; Cells, Cultured; Cerebral Cortex; Cytokines; Disease Models, Animal; DNA Fragmentation; Infusions, Intraventricular; Male; Mice; Mice, Inbred C57BL; Microfilament Proteins; Neurons; Optic Nerve Injuries; Platelet Aggregation Inhibitors; Receptors, Purinergic P2; Rosaniline Dyes	2017
Neuroprotective effects of brilliant blue G on the brain following traumatic brain injury in rats. Molecular medicine reports, 2015, Volume: 12, Issue:2 Topics: Animals; Brain; Brain Edema; Brain Injuries; Interleukin-1beta; Neuroprotective Agents; Protein Kinase C; Purinergic P2X Receptor Antagonists; Rats, Sprague-Dawley; Receptors, Purinergic P2X7; Rosaniline Dyes	2015

Article

Year

Evidence that activation of P2X7R does not exacerbate neuronal death after optic nerve transection and focal cerebral ischemia in mice.

Experimental neurology, 2017, Volume: 296

Topics: Adenosine Triphosphate; Animals; Animals, Newborn; Brain; Brain Edema; Brain Ischemia; Calcium-Binding Proteins; Cells, Cultured; Cerebral Cortex; Cytokines; Disease Models, Animal; DNA Fragmentation; Infusions, Intraventricular; Male; Mice; Mice, Inbred C57BL; Microfilament Proteins; Neurons; Optic Nerve Injuries; Platelet Aggregation Inhibitors; Receptors, Purinergic P2; Rosaniline Dyes

2017

Neuroprotective effects of brilliant blue G on the brain following traumatic brain injury in rats.

Molecular medicine reports, 2015, Volume: 12, Issue:2

Topics: Animals; Brain; Brain Edema; Brain Injuries; Interleukin-1beta; Neuroprotective Agents; Protein Kinase C; Purinergic P2X Receptor Antagonists; Rats, Sprague-Dawley; Receptors, Purinergic P2X7; Rosaniline Dyes

2015